Table 2 Potential predictors of adrenal suppression

Female sex (N,  %)

3/10 (30 %)

4/19 (21.1 %)

0.66^a

Age (median, IQR)

15.15 (4.75)

13.81 (4.66)

0.31^b

Duration of GC therapy (days)

113.5 ± 30.44

99.8 ± 18.44

0.22^c

BMI

18.2 ± 2.54

19.3 ± 3.15

0.33^c

Concurrent use of ICS therapy (intermittent or continuous)

2/10 (20 %)

9/19 (47.3 %)

0.23^a

Concurrent use of ICS therapy (continuous only)

1/10 (10 %)

5/19 (26.3 %)

0.63^a